Look beyond viral suppression to learn how people living with virologically suppressed HIV may still be candidates for antiretroviral therapy (ART) switch to improve treatment satisfaction and quality of life. Topics covered include:

• Reasons to consider regimen optimization in setting of viral suppression
• Available switch regimens, including 2-drug regimens and long-acting ART
• Approaches to assess for resistance before starting long-acting cabotegravir plus rilpivirine 
• DHHS recommendations on proviral DNA genotyping
• ART optimization strategies for patients living with viral suppression and history of underlying resistance

Presenters:

Brian R. Wood, MD
Professor of Medicine
Division of Allergy and Infectious Diseases
University of Washington
Seattle, Washington

Cristina Mussini, MD
Professor of Infectious Diseases
Chief of the Division of Infectious Diseases, Policlinico, Modena
University of Modena and Reggio Emilia
Modena, Italy 

Link to full program and accompanying slides: 
https://bit.ly/4pAI66g

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.